Genomind Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Genomind Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011706
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing products. The company’s product portfolio includes The Genecept Assay, a genetic test developed for clinicians to optimize treatment decisions for their patients with mental illness. Its assay finds patient-specific genetic markers, analyzes key genes and gives treatment decisions. Genomind’s product is used to guide treatment for a range of psychiatric conditions including depression, anxiety, obsessive compulsive disorder, attention deficit disorder, bipolar disorder, post-traumatic stress disorder, autism and schizophrenia. The company also offers pharmacogenetic laboratory testing for psychiatry. It serves clinicians and patients. Genomind is headquartered in King of Prussia, Pennsylvania, the US.

Genomind Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genomind Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genomind Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genomind Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genomind Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Genomind Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genomind Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Genomind Raises USD11 Million in Venture Financing 10
Genomind Raises USD3 Million in Venture Financing 11
Genomind Raises USD2.2 Million in Venture Financing 12
Genomind Raises USD2 Million in Venture Financing 13
Genomind Raises USD6 Million in Venture Financing 14
Genomind Raises US$5 Million In Venture Financing 15
Genomind Enters Into Licensing Agreement With Emory University 16
Genomind Inc – Key Competitors 17
Genomind Inc – Key Employees 18
Genomind Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Product News 20
02/09/2016: Genetic Testing for Mental Health Approved as New Ally for Military Personnel and Veterans 20
01/19/2016: Clinicians and Patients Gain Powerful Advanced Test for Mental Health as the Genecept Assay Builds on Existing Patient Success 21
Other Significant Developments 22
Jan 09, 2017: Genomind Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Genomind Inc, Medical Equipment, Key Facts 2
Genomind Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Genomind Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Genomind Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Genomind Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Genomind Inc, Deals By Market, 2011 to YTD 2017 8
Genomind Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Genomind Raises USD11 Million in Venture Financing 10
Genomind Raises USD3 Million in Venture Financing 11
Genomind Raises USD2.2 Million in Venture Financing 12
Genomind Raises USD2 Million in Venture Financing 13
Genomind Raises USD6 Million in Venture Financing 14
Genomind Raises US$5 Million In Venture Financing 15
Genomind Enters Into Licensing Agreement With Emory University 16
Genomind Inc, Key Competitors 17
Genomind Inc, Key Employees 18

★海外企業調査レポート[Genomind Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Keck Seng Investments (Hong Kong) Ltd:企業の戦略・SWOT・財務分析
    SummaryKeck Seng Investments (Hong Kong) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • American Cruise Lines, Inc.:企業の戦略・SWOT・財務分析
    SummaryAmerican Cruise Lines, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Cantargia AB (CANTA):企業財務及び戦略的SWOT分析
    Summary Cantargia AB (Cantargia) a subsidiary of Lund University Bioscience AB is a pharmaceutical company that offers research and development services. The company develops antibodies for treatment of haematological diseases. It provides therapies for the treatment of hematological malignancies th …
  • Forrester Research, Inc. (FORR):企業概要、財務及び戦略的SWOT分析
    Summary Forrester Research, Inc. (FRI) is a research service provider. The company provides research and various advisory services to the business and technological issues. It provides research, consumer and business data, events and online communities, custom consulting, and peer-to-peer executive …
  • Rogers Communications, Inc.:企業のM&A・提携・投資分析
    Rogers Communications, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rogers Communications, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Avacta Group PLC (AVCT):企業概要、財務及び戦略的SWOT分析
    Summary Avacta Group PLC (Avacta) is a healthcare technology company. The company provides innovative and proprietary solutions to the life sciences and healthcare sector. It operates with Avacta analytical, Avacta animal health, Avacta life sciences and Animal allergy divisions. Avacta offers produ …
  • X-Chem Inc-製薬・医療分野:企業M&A・提携分析
    Summary X-Chem Inc (X-Chem) is a biotechnology company that focuses on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics. The company’s drug discovery engine is based on a library generated by iterative combinatorial synthesis of small molecules. …
  • Gujarat Sidhee Cement Limited (GUJSIDHCEM):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Gujarat Sidhee Cement Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stri …
  • PanGenex Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PanGenex Corporation Mergers an …
  • Bridgelux Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary BridgeLux Inc. (BridgeLux) is an electrical products company that manufactures semiconductors. The company develops and manufactures light-emitting diode lighting technologies and solutions. Its products include OLM series, Vero series, V series, BXRA3 series and LED chips. BridgeLux’s produ …
  • Tetra Tech, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tetra Tech, Inc. Mergers and Ac …
  • National Oilwell Varco, Inc. (NOV):企業のM&A・提携動向(石油・ガス分野)
    Summary National Oilwell Varco, Inc. (NOV) is an industrial equipment company, which designs and manufactures equipment and components for the oil and gas sector. It portfolio includes rig systems, wellbore technologies, and completion and production technologies. Its product line comprises fiber gl …
  • Intralot SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intralot SA Mergers and Acquisi …
  • OAO Gazprom:企業のM&A・提携・投資分析
    OAO Gazprom - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OAO Gazprom Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • BLandH Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BLandH Co., Ltd. Mergers and Ac …
  • First Gen Corporation (FGEN):企業のM&A・提携動向(発電分野)
    Summary First Gen Corporation (First Gen), a subsidiary of First Philippine Holding Corporation, is a producer and distributor of electric power. It undertakes activities such as power generation, power distribution, infrastructure, manufacturing, and property development. The company, together with …
  • Iconix Brand Group, Inc.:企業のM&A・提携・投資分析
    Iconix Brand Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iconix Brand Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Chrysaor Holdings Limited:企業のM&A・提携動向(石油・ガス分野)
    Summary Chrysaor Holdings Limited (Chrysaor) is an oil and gas company that offers exploration services. The company explores, develops, produces, and commercializes oil and gas discoveries in the North Sea and Ireland. It owns and operates various assets and resources including Solan, Phoenix and W …
  • Shandong Lubei Chemical Co., Ltd. (600727):企業財務及び戦略的SWOT分析
    Summary Shandong Lubei Chemical Co., Ltd. (Lubei Chemical) is a chemical company that develops and markets chemical products and fertilizers. The company’s products include salt, DAP, cement, compound fertilizer, bromine and sulfuric acid. Its salt is used for production of soda ash, caustic soda, s …
  • King Wan Corporation Limited:企業の戦略・SWOT・財務分析
    SummaryKing Wan Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆